Planta Med 2004; 70(6): 520-525
DOI: 10.1055/s-2004-827151
Original Paper
Pharmacology
© Georg Thieme Verlag KG Stuttgart · New York

In vitro and in vivo Antimalarial Properties of Isostrychnopentamine, an Indolomonoterpenic Alkaloid from Strychnos usambarensis

Michel Frédérich1 , 2 , Monique Tits1 , Eric Goffin1 , Geneviève Philippe1 , Philippe Grellier3 , Patrick De Mol2 , Marie-Pierre Hayette2 , Luc Angenot1
  • 1Natural and Synthetic Drug Research Center, Laboratory of Pharmacognosy, University of Liège, Liège, Belgium
  • 2Laboratory of Medical Microbiology, University of Liège, Liège, Belgium
  • 3Laboratoire de Biologie parasitaire, USM 0504, Département RDDM, Muséum National d'Histoire Naturelle, Paris, France
This research was supported by the Belgian National Fund for Scientific Research (FNRS) (grant No 3 453 201 and fellowship for M.F.)
Further Information

Publication History

Received: November 26, 2003

Accepted: March 7, 2004

Publication Date:
01 July 2004 (online)

Abstract

Isostrychnopentamine (ISP) is an asymmetric indolomonoterpenic alkaloid isolated from the leaves of Strychnos usambarensis. The in vitro antiplasmodial activities against five Plasmodium falciparum cell lines were evaluated: ISP possessed an in vitro IC50 near 0.1 μM against all P. falciparum cell lines tested (chloroquine-resistant and chloroquine-sensitive lines) and showed antiplasmodial selectivity compared to cytotoxicity on human cell lines. The stage-dependent susceptibility to a short exposure of ISP was then investigated. The ring stage was shown to be the most sensitive one, but all stages were affected by ISP treatment. By means of fluorescence microscopy, it was shown that ISP was not accumulated inside the food vacuole of the parasite. Finally, the in vivo antimalarial activities against the P. berghei NK173 and P. vinckei petteri murine strains were determined. The ED50 in vivo was about 30 mg/kg/day by the intraperitoneal route (after 4 days treatment).

References

  • 1 White N J. Drug resistance in malaria.  Br Med Bull. 1998;  54 703-15
  • 2 Angenot L, Dubois M, Ginion C, van Dorsser W, Dresse A. Chemical structure and pharmacological (curarizing) properties of various indole alkaloids extracted from an African Strychnos .  Arch Int Pharmacodyn Ther. 1975;  215 246-58
  • 3 Angenot L, Coune C, Tits M. Nouveaux alcaloïdes des feuilles du Strychnos usambarensis .  J Pharm Belg. 1978;  33 11-23
  • 4 Caprasse M, Angenot L, Tavernier D, Anteunis M JO. Isolement et détermination de structure de l'afrocurarine.  Planta Med. 1984;  50 117-204
  • 5 Frederich M, Quetin-Leclercq J, Gadi-Biala R, Brandt V, Penelle J, Tits M, Angenot L. 3′,4′,5′,6′-Tetradehydrolongicaudatine Y, an anhydronium base from Strychnos usambarensis .  Phytochemistry. 1998;  48 1263-6
  • 6 Tavernier D, Zhang W, Angenot L, Tits M, Leclercq J. The structure of isostrychnopentamine, a bisindole monoterpene alkaloid from Strychnos usambarensis .  Phytochemistry. 1987;  26 557-60
  • 7 Frederich M, Bentires-Alj M, Tits M, Angenot L, Greimers R, Gielen J. et al . Isostrychnopentamine, an indolomonoterpenic alkaloid from Strychnos usambarensis, induces cell cycle arrest and apoptosis in human colon cancer cells.  J Pharmacol Exp Ther. 2003;  304 1103-10
  • 8 Frederich M, Jacquier M J, Thepenier P, De Mol P, Tits M, Philippe G. et al . Antiplasmodial activity of alkaloids from various Strychnos species.  J Nat Prod. 2002;  65 1381-6
  • 9 Wright C W, Bray D H, O'Neill M J, Warhurst D C, Phillipson J D, Quetin-Leclercq J, Angenot L. Antiamoebic and antiplasmodial activities of alkaloids isolated from Strychnos usambarensis .  Planta Med. 1991;  57 337-40
  • 10 Trager W, Jensen J B. Human malaria parasites in continuous culture.  Science. 1976;  193 673-5
  • 11 Frederich M, Depauw-Gillet M C, Llabres G, Tits M, Hayette M P, Brandt V. et al . New antimalarial and cytotoxic sungucine derivatives from Strychnos icaja roots.  Planta Med. 2000;  66 262-9
  • 12 Desjardins R E, Canfield C J, Haynes J D, Chulay J D. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique.  Antimicrob Agents Chemother. 1979;  16 710-8
  • 13 Mirovsky P, Gay F, Bustos D, Mazier D, Gentilini M. Cloning of a fresh isolate of Plasmodium falciparum and drug sensitivity of the clones.  Trans R Soc Trop Med Hyg. 1990;  84 511-5
  • 14 Jensen J B. Concentration from continuous culture of erythrocytes infected with trophozoites and schizonts of Plasmodium falciparum .  Am J Trop Med Hyg. 1978;  27 1274-6
  • 15 Lambros C, Vanderberg J P. Synchronization of Plasmodium falciparum erythrocytic stages in culture.  J Parasitol. 1979;  65 418-20
  • 16 Frederich M, Jacquier M J, Thepenier P, De Mol P, Tits M, Philippe G. et al . Antiplasmodial activity of alkaloids from various Strychnos species.  J Nat Prod. 2002;  65 1381-6
  • 17 Peters W, Robinson B L. The chemotherapy of rodent malaria. XLVI. Reversal of mefloquine resistance in rodent Plasmodium .  Ann Trop Med Parasitol. 1991;  85 5-10
  • 18 Skinner T S, Manning L S, Johnston W A, Davis T M. In vitro stage-specific sensitivity of Plasmodium falciparum to quinine and artemisinin drugs.  Int J Parasitol. 1996;  26 519-25
  • 19 Lauer S A, Rathod P K, Ghori N, Haldar K. A membrane network for nutrient import in red cells infected with the malaria parasite.  Science. 1997;  276 1122-5
  • 20 Frederich M, Hayette M P, Tits M, De Mol P, Angenot L. In vitro activities of Strychnos alkaloids and extracts against Plasmodium falciparum .  Antimicrob Agents Chemother. 1999;  43 2328-31
  • 21 Benoit-Vical F, Imbert C, Bonfils J P, Sauvaire Y. Antiplasmodial and antifungal activities of iridal, a plant triterpenoid.  Phytochemistry. 2003;  62 747-51
  • 22 Tona L, Mesia K, Ngimbi N P, Chrimwami B, Okond' Ahoka, Cimanga K. et al . In-vivo antimalarial activity of Cassia occidentalis, Morinda morindoides and Phyllanthus niruri .  Annals of Tropical Medicine and Parasitology. 2001;  95 47-57

Michel Frédérich

Laboratory of Pharmacognosy

Natural and Synthetic Drug Research Center

University of Liège

Avenue de l'hôpital 1, B36

4000 Liège

Belgium

Phone: +32-4-366-4338

Fax: +32-4-366-4332

Email: M.Frederich@ulg.ac.be